XIAP and prostate carcinoma: This was consistent with previous studies which demonstrated controversial prognostic role of XIAP for cancer patients with increased XIAP expression predicting shorter overall survival in acute myeloid leukemia (AML) but longer overall survival in cervical carcinoma [20–22], prostate cancer [23] and lung cancer [24].